Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage

Histopathology

Volumn 48, Issue 7, 2006, Pages 846-854

  Yamada, T ^a   Uehara, K ^a   Kawanishi, R ^a   Mizutani, T ^a   Sunagawa, K ^a   Araya, J ^b   Kawabata, Y ^c  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Saitama Cardiovascular and Respiratory Center   (Japan)

Author keywords

Diffuse alveolar damage; Intracytoplasmic eosinophilic inclusion body; Pneumocyte; Ubiquitin

Indexed keywords

CYTOKERATIN; HYALIN; PROTEASOME; UBIQUITIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOACCUMULATION; CELL GRANULE; CELL INCLUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG LOBE; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN DETERMINATION; SCORING SYSTEM; TISSUE SECTION; UBIQUITINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOPLASM; EOSINE YELLOWISH-(YS); FEMALE; HUMANS; HYALIN; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PULMONARY ALVEOLI; UBIQUITIN;

EID: 33744462067     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02445.x     Document Type: Article

References (29)

1. Lennox G, Lowe J, Morrell K et al. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J. Neurol. Neurosurg. Psychiatry 1989 52 67 71.
2. Galloway PG, Grundke-Iqbal I, Iqbal K et al. Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 1988 47 654 663.
3. Manetto V, Perry G, Tabaton M et al. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 1988 85 4501 4505.
4. Lennox G, Lowe J, Landon M et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J. Neurol. Neurosurg. Psychiatry 1989 52 1236 1247.
5. Love S, Saitoh T, Quijada S et al. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J. Neuropathol. Exp. Neurol. 1988 47 393 405.
6. Shimura H, Schlossmacher MG, Hattori N et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001 293 263 269.
7. Ardley HC, Scott GB, Rose SA et al. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Mol. Biol. Cell 2003 14 4541 4556.
8. Kawanishi R, Mizutani T, Yamada H et al. Ubiquitin-positive inclusions in ependymal cells. Acta Neuropathol. 2003 106 129 136.
9. Kusama H, Takizawa N. A case of lung cancer with Mallory bodies. Rinsho Byori 1992 40 210 214.
10. Nonomura A, Saito K, Kono N et al. Cytoplasmic hyalins resembling Mallory's alcoholic hyalins in pulmonary carcinoma cells. Acta Pathol. Jpn 1986 36 1669 1677.
11. Lowe J, Blanchard A, Morrell K et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol. 1988 155 9 15.
12. Flieder DB, Travis WD. Clear cell 'sugar' tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am. J. Surg. Pathol. 1997 21 1242 1247.
13. del Rosario AD, Bui HX, Singh J et al. Intracytoplasmic eosinophilic hyaline globules in cartilaginous neoplasms: a surgical, pathological, ultrastructural, and electron probe x-ray microanalytic study. Hum. Pathol. 1994 25 1283 1289.
14. Gould VE, Miller J. Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair. Am. J. Pathol. 1975 81 513 530.
15. Yamada T, Kawanishi R, Yamada H et al. An autopsy case of ubiquitin-positive eosinophilic intracytoplasmic inclusion bodies in alveolar epithelium. Kokyu TO Junkan 2004 52 759 763 (in Japanese).
16. Kuhn C3rd, Kuo TT. Cytoplasmic hyalin in asbestosis. A reaction of injured alveolar epithelium. Arch. Pathol. 1973 95 190 194.
17. Warnock ML, Press M, Churg A. Further observations on cytoplasmic hyaline in the lung. Hum. Pathol. 1980 11 59 65.
18. Shimizu S, Kobayashi H, Watanabe H et al. Mallory body-like structures in the lung. Acta Pathol. Jpn 1986 36 105 112.
19. Schiffer D, Autilio-Gambetti L, Chio A et al. Ubiquitin in motor neuron disease: study at the light and electron microscope. J. Neuropathol. Exp. Neurol. 1991 50 463 473.
20. Murayama S, Mori H, Ihara Y et al. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 1990 27 137 148.
21. Franks TJ, Chong PY, Chui P et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 2003 34 743 748.
22. Nicholls JM, Poon LL, Lee KC et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003 24 361 1773 1778.
23. Duan W, Gao L, Druhan LJ et al. Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. J. Natl Cancer Inst. 2004 17 1718 1721.
24. Li M, Chen D, Shiloh A et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002 416 648 653.
25. Chang YC, Lee YS, Tejima T et al. Mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 1998 9 79 84.
26. Araya J, Maruyama M, Inoue A et al. Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 2002 283 L849 858.
27. Mortenson MM, Schlieman MG, Virudachalam S et al. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother. Pharmacol. 2004 54 343 353.
28. Esposito C, Marra M, Giuberti G et al. Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells. Biochem. J. 2003 370 205 212.
29. Fisseler-Eckhoff A, Erfkamp S, Muller KM. Cytokeratin expression in preneoplastic lesions and early squamous cell carcinoma of the bronchi. Pathol. Res. Pract. 1996 192 552 559.